• 89,99 €

Descrizione dell’editore

This comprehensive update on irritable bowel syndrome addresses both the state of art diagnosis and treatment as well as emerging therapies and future directions. Worldwide authority, Dr. Eammon Quigley, contributes an article on Therapies Aimed at the Gut Microflora and Inflammation. Other highlights include articles devoted to genetics, biomarkers, and symptom-based diagnostic criteria.

GENERE
Professionali e tecnici
PUBBLICATO
2011
21 marzo
LINGUA
EN
Inglese
PAGINE
280
EDITORE
Elsevier Health Sciences
DIMENSIONE
12.5
MB